This is an Internet-based survey of transgender and transsexual (trans) people aged 18 years and older living in Australia. This population has received limited attention from public health researchers, planners, and practitioners. However, a growing body of evidence suggests that trans people experience disparities in several important areas of health compared with the population generally. In particular, trans people are more likely to experience mental health problems (notably depression and anxiety disorders), use alcohol, tobacco, and illicit drugs, and think about or attempt suicide. Additionally, trans people commonly report that their physical and mental health needs are not met, and underutilise preventive health care. Participants were recruited using several non-probability sampling techniques, (including purposive sampling and snowball sampling), because random sampling is not possible with this population. Medical, social, support, and advocacy networks used by trans people were used to promote the study. A mixed quantitative and qualitative methodology was used. Validated quantitative instruments were used to obtain measures of health and well-being, which will be compared against population norms. Qualitative items complement these measures, providing rich experiential data. The investigators hypothesised that: * the prevalence of depressive and anxiety disorders will be higher than for the population generally, and that these conditions will commonly be undiagnosed and untreated; * depressive and anxiety disorders will be associated with risky behaviours, such as tobacco, alcohol, and illicit drug use; and, * trans people will report poor relationships with medical practitioners. The investigators hypothesised that poor mental health is a consequence of several interrelated factors: body dysphoria (as a consequence of experiencing difficulty accessing medical treatment to alter sexual characteristics); societal discrimination and stigma (including harassment and violence); institutionalised discrimination (including difficulty changing identifying documents, and exclusion of surgical procedures and related treatments from public and private health systems); social isolation; and the belief held by many clinicians that transsexualism is a mental disorder (which may be a barrier to trans people forming trusting relationships with medical practitioners).
Study Type
OBSERVATIONAL
Enrollment
946
Curtin University
Perth, Western Australia, Australia
Prevalence of depressive and anxiety disorders
Assessed by self-report, and with the Patient Health Questionnaire (PHQ)
Time frame: At time of entry into study (cross-sectional)
Perceived physical and mental health status
Assessed with the 36-item Short Form Health Survey (SF-36)
Time frame: At time of entry into study (cross-sectional)
Use of alcohol, tobacco, and illicit drugs
Assessed by self-report
Time frame: At time of entry into study (cross-sectional)
Patient-doctor relationship between trans people and their general practitioners, and doctors generally
Assessed with the Patient-Doctor Relationship Questionnaire (PDRQ-9) and other quantitative and qualitative questions
Time frame: At time of entry into study (cross-sectional)
Body image
Assessed with the Body Image Quality of Life Inventory (BIQLI)
Time frame: At time of entry into study (cross-sectional)
Factors that encourage and discourage trans people from accessing health care
Assessed with qualitative questions
Time frame: At time of entry into study (cross-sectional)
Factors that protect and promote mental health in trans people
Assessed with qualitative questions
Time frame: At time of entry into study (cross-sectional)
Use of hormone therapy and desire for, and uptake of transition-related surgery
Assessed with quantitative and qualitative questions
Time frame: At time of entry into study (cross-sectional)
Experiences of discrimination and harassment
Assessed with quantitative and qualitative questions
Time frame: At time of entry into study (cross-sectional)
Desire to, and success changing identifying documentation
Assessed with quantitative and qualitative questions
Time frame: At time of entry into study (cross-sectional)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.